Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia.
NCT06590662
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Idiopathic Hypersomnia
Interventions
DRUG:
Solriamfetol
DRUG:
Placebo
Sponsor
University Hospital, Montpellier